KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
DMA 100DMA 200DMA 50Dividend YieldEV to CFOEV to EBITEV to EBITDAEV to FCFEV to RevenueEnterprise ValueMarket Cap to FCFMarket CapitalizationPricePrice to EarningsPrice to Sales
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Teladoc Health (TDOC) Enterprise Value (2016 - 2026)

Teladoc Health's Enterprise Value history spans 14 years, with the latest figure at -$750.7 million for Q1 2026.

  • On a quarterly basis, Enterprise Value rose 37.09% to -$750.7 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$750.7 million, a 37.09% increase, with the full-year FY2025 number at -$781.1 million, up 39.84% from a year prior.
  • Enterprise Value hit -$750.7 million in Q1 2026 for Teladoc Health, up from -$781.1 million in the prior quarter.
  • Over the last five years, Enterprise Value for TDOC hit a ceiling of -$679.6 million in Q2 2025 and a floor of -$1.3 billion in Q4 2024.
  • Historically, Enterprise Value has averaged -$969.1 million across 5 years, with a median of -$918.2 million in 2022.
  • Biggest five-year swings in Enterprise Value: decreased 23.56% in 2024 and later soared 41.61% in 2025.
  • Tracing TDOC's Enterprise Value over 5 years: stood at -$918.2 million in 2022, then dropped by 22.38% to -$1.1 billion in 2023, then decreased by 15.54% to -$1.3 billion in 2024, then soared by 39.84% to -$781.1 million in 2025, then rose by 3.89% to -$750.7 million in 2026.
  • Business Quant data shows Enterprise Value for TDOC at -$750.7 million in Q1 2026, -$781.1 million in Q4 2025, and -$726.2 million in Q3 2025.